Related Experiment Videos

Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino

H Nikaido1, W Liu, E Y Rosenberg

  • 1Department of Molecular and Cell Biology, University of California, Berkeley 94720.

Insights

Newer cephalosporins are more effective against resistant bacteria due to faster cell entry and slower breakdown by beta-lactamases. This dual action improves treatment outcomes for infections caused by resistant enteric bacteria.

Area of Science:

  • Microbiology
  • Pharmacology
  • Biochemistry

Background:

  • Enteric bacteria like Enterobacter cloacae develop resistance to broad-spectrum cephalosporins by overproducing type I beta-lactamases.
  • High-affinity hydrolysis by beta-lactamases renders these antibiotics ineffective at low concentrations.
  • Newer cephalosporins with specific structural modifications show promise against resistant strains.

Purpose of the Study:

  • To investigate the contribution of outer membrane permeability to the efficacy of newer cephalosporins.
  • To compare the porin channel penetration rates of newer and older cephalosporins.
  • To evaluate the hydrolysis kinetics of these agents by bacterial beta-lactamases.

Main Methods:

  • Proteoliposome swelling assays were used to measure porin channel penetration.
  • Kinetic parameters of hydrolysis by Enterobacter cloacae beta-lactamase were determined.
  • In silico analysis considered the Donnan potential's effect on intact cell penetration.

Main Results:

  • Cefepime, cefpirome, and E-1040 showed significantly faster porin channel penetration than ceftazidime.
  • These newer agents are hydrolyzed more slowly by E. cloacae beta-lactamase compared to cefotaxime.
  • Combined effects suggest 2-10 times faster penetration into intact cells for newer cephalosporins.

Conclusions:

  • Enhanced outer membrane permeability and reduced hydrolysis contribute to the increased efficacy of newer cephalosporins.
  • These factors quantitatively explain the improved effectiveness against beta-lactamase-overproducing gram-negative bacteria.
  • The findings support the clinical utility of these advanced cephalosporins in treating resistant infections.

Related Concept Videos